Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?

To: rjm2 who wrote (11278)	10/13/2000 2:23:00 AM
From: Tomato	Read Replies (1) \| Respond to of 78625

Has anyone taken a look at KDUS? Illiquid biotech shell (1 employee who is also Carl Icahn's main man, I think)13.5 mil shares O/S, 25% of which are owned by Carl Icahn. About $25 mil. in cash ($1.90/sh), assuming the $19.5 mil they placed in an escrow acct. to pay a judgment against them that was reversed on appeal is returned to them. Royalty income and shares in a privately held biotech company worth ?????. Richard Harmon, who is one of the smartest SI biotech posters owns it. I can't see the downside, but then I started buying at $1.25 and it's at 97 cents now. I'd be interested in someone's opinion.